Citation: Pc. Ho et al., VAGINAL MISOPROSTOL COMPARED WITH ORAL MISOPROSTOL IN TERMINATION OF 2ND-TRIMESTER PREGNANCY, Obstetrics and gynecology, 90(5), 1997, pp. 735-738
Citation: Sw. Ngai et al., ORAL MISOPROSTOL VERSUS MIFEPRISTONE FOR CERVICAL DILATATION BEFORE VACUUM ASPIRATION IN FIRST TRIMESTER NULLIPAROUS PREGNANCY - A DOUBLE-BLIND PROSPECTIVE RANDOMIZED STUDY, British journal of obstetrics and gynaecology, 103(11), 1996, pp. 1120-1123
Citation: Sw. Ngai et al., CERVICAL PRIMING WITH ORAL MISOPROSTOL IN PRE-LABOR RUPTURE OF MEMBRANES AT TERM, Obstetrics and gynecology, 87(6), 1996, pp. 923-926
Citation: Sw. Ngai et al., ORAL MISOPROSTOL VERSUS PLACEBO FOR CERVICAL DILATATION BEFORE VACUUMASPIRATION IN FIRST TRIMESTER PREGNANCY, Human reproduction, 10(5), 1995, pp. 1220-1222
Citation: Sw. Ngai et al., ORAL MISOPROSTOL VERSUS VAGINAL GEMEPROST FOR CERVICAL DILATATION PRIOR TO VACUUM ASPIRATION IN WOMEN IN THE 6H TO 12TH WEEK OF GESTATION, Contraception, 51(6), 1995, pp. 347-350